生物利用度
化学
药理学
传统医学
生化工程
医学
工程类
作者
Monika Stompor,Daniel Broda,Agata Bajek-Bil
出处
期刊:Molecules
[Multidisciplinary Digital Publishing Institute]
日期:2019-12-05
卷期号:24 (24): 4468-4468
被引量:67
标识
DOI:10.3390/molecules24244468
摘要
Dihydrochalcones are a class of secondary metabolites, for which demand in biological and pharmacological applications is still growing. They posses several healthendorsing properties and, therefore, are promising candidates for further research and development. However, low content of dihydrochalcones in plants along with their low solubility and bioavailability restrict the development of these compounds as clinical therapeutics. Therefore, chemomicrobial and enzymatic modifications are required to expand their application. This review aims at analyzing and summarizing the methods of obtaining dihydrochalcones and of presenting their pharmacological actions that have been described in the literature to support potential future development of this group of compounds as novel therapeutic drugs. We have also performed an evaluation of the available literature on beneficial effects of dihydrochalcones with potent antioxidant activity and multifactorial pharmacological effects, including antidiabetic, antitumor, lipometabolism regulating, antioxidant, antiinflammatory, antibacterial, antiviral, and immunomodulatory ones. In addition, we provide useful information on their properties, sources, and usefulness in medicinal chemistry.
科研通智能强力驱动
Strongly Powered by AbleSci AI